
Clinical Trial Supplies Market Intelligence Report - Global Forecast to 2027
Description
The Global Clinical Trial Supplies Market is projected to reach USD 32,742.34 million by 2027 from USD 20,984.94 million in 2021, at a CAGR 7.69% during the forecast period.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.
- The Americas Clinical Trial Supplies Market size was estimated at USD 8,238.68 million in 2021 and expected to reach USD 8,860.65 million in 2022, at a CAGR 7.65% to reach USD 12,825.63 million by 2027.
- The Asia-Pacific Clinical Trial Supplies Market size was estimated at USD 4,691.18 million in 2021 and expected to reach USD 5,094.62 million in 2022, at a CAGR 7.99% to reach USD 7,443.63 million by 2027.
- The Europe, Middle East & Africa Clinical Trial Supplies Market size was estimated at USD 8,055.07 million in 2021 and expected to reach USD 8,639.78 million in 2022, at a CAGR 7.55% to reach USD 12,473.06 million by 2027.
Market Segmentation & Coverage:
The report on clinical trial supplies identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.
This research report categorizes the clinical trial supplies to forecast the revenues and analyze the trends in each of the following sub-markets:
Services:
- Comparator Sourcing
- Logistics & Distribution
- Cold Chain Distribution
- Non-Cold Chain Distribution
- Manufacturing
- Packaging, Labeling, & Blinding
- Storage & Retention
Type:
- Biologic Drugs
- Medical Devices
- Small Molecules
Phase:
- BA/ BE studies
- Phase 1
- Phase 2
- Phase 3
- Phase 4
Therapeutic Area:
- Blood Disorders
- Cardiovascular Diseases
- CNS & Mental Disorders
- Dermatological Disorders
- Digestive Disorders
- ENT Diseases
- Immunology
- Infectious Diseases
- Metabolic Disorders
- Nephrology
- Oncology
- Rare Diseases
- Respiratory Disorders
End User:
- Contract Research Organisations (CROs)
- Medical Devices Companies
- Pharmaceutical & Biotechnology companies
Region:
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- Arizona
- California
- Florida
- Illinois
- New York
- North Carolina
- Ohio
- Oregon
- Pennsylvania
- Tennessee
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Europe, Middle East & Africa
- France
- Germany
- Italy
- Netherlands
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- United Arab Emirates
- United Kingdom
Company Usability Profiles:
- Almac Group
- Ancillare, LP
- Biocair International Limited
- Catalent, Inc.
- Clinigen Group PLC
- Eurofins Scientific Group
- ICON PLC
- Infosys Limited
- KLIFO A/S
- Liveo Research GmbH
- Lonza Group AG
- Marken Limited
- Myonex, Inc.
- N-SIDE SA
- Parexel International Corporation
- PCI Pharma Services
- Piramal Pharma Solutions
- SIRO Clinpharm Private Limited
- Thermo Fisher Scientific, Inc.
- UDG Healthcare PLC
- Walden
Base Year: 2021
Estimated Year: 2022
Forecast Year: 2027
Base Year Value: USD 20,984.94 million
Estimated Year Value: USD 22,595.06 million
Forecast Year Value: USD 32,742.34 million
CAGR (%): 7.69%.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Market Overview
- 4. Americas Clinical Trial Supplies Market
- 4.1. Introduction
- 4.2. Argentina
- 4.3. Brazil
- 4.4. Canada
- 4.5. Mexico
- 4.6. United States
- 5. Asia-Pacific Clinical Trial Supplies Market
- 5.1. Introduction
- 5.2. Australia
- 5.3. China
- 5.4. India
- 5.5. Indonesia
- 5.6. Japan
- 5.7. Malaysia
- 5.8. Philippines
- 5.9. Singapore
- 5.10. South Korea
- 5.11. Taiwan
- 5.12. Thailand
- 6. Europe, Middle East & Africa Clinical Trial Supplies Market
- 6.1. Introduction
- 6.2. France
- 6.3. Germany
- 6.4. Italy
- 6.5. Netherlands
- 6.6. Qatar
- 6.7. Russia
- 6.8. Saudi Arabia
- 6.9. South Africa
- 6.10. Spain
- 6.11. United Arab Emirates
- 6.12. United Kingdom
- 7. Company Usability Profiles
- 7.1. Almac Group
- 7.2. Ancillare, LP
- 7.3. Biocair International Limited
- 7.4. Catalent, Inc.
- 7.5. Clinigen Group PLC
- 7.6. Eurofins Scientific Group
- 7.7. ICON PLC
- 7.8. Infosys Limited
- 7.9. KLIFO A/S
- 7.10. Liveo Research GmbH
- 7.11. Lonza Group AG
- 7.12. Marken Limited
- 7.13. Myonex, Inc.
- 7.14. N-SIDE SA
- 7.15. Parexel International Corporation
- 7.16. PCI Pharma Services
- 7.17. Piramal Pharma Solutions
- 7.18. SIRO Clinpharm Private Limited
- 7.19. Thermo Fisher Scientific, Inc.
- 7.20. UDG Healthcare PLC
- 7.21. Walden
Pricing
Currency Rates